Saturday, Apr 27, 2024
logo
Update At 14:00    USD/EUR 0,92  ↑+0.0002        USD/JPY 151,69  ↑+0.174        USD/KRW 1.347,35  ↑+6.1        EUR/JPY 164,16  ↑+0.143        Crude Oil 85,49  ↓-0.76        Asia Dow 3.838,83  ↑+1.8        TSE 1.833,50  ↑+4.5        Japan: Nikkei 225 40.846,59  ↑+448.56        S. Korea: KOSPI 2.756,23  ↓-0.86        China: Shanghai Composite 3.015,74  ↓-15.745        Hong Kong: Hang Seng 16.512,92  ↓-105.4        Singapore: Straits Times 3,27  ↑+0.018        DJIA 22,58  ↓-0.23        Nasdaq Composite 16.315,70  ↓-68.769        S&P 500 5.203,58  ↓-14.61        Russell 2000 2.070,16  ↓-4.0003        Stoxx Euro 50 5.064,18  ↑+19.99        Stoxx Europe 600 511,09  ↑+1.23        Germany: DAX 18.384,35  ↑+123.04        UK: FTSE 100 7.930,96  ↑+13.39        Spain: IBEX 35 10.991,50  ↑+39.3        France: CAC 40 8.184,75  ↑+33.15        

Pioneering healthcare innovation: Daiichi Medical’s vision for transforming patient care

Flag USAFlag JAPAN
Article - March 27, 2024

Daiichi Medical is aiming to explore the intersection of medical technology, global expansion, and patient-centered solutions through its ENT treatment for global healthcare excellence.

In an aging Japan, where the emphasis is shifting towards preventive healthcare, Daiichi Medical stands at the forefront of innovation, with digital technologies being pivotal.

With a focus on otolaryngology and equilibrium research, it has pioneered solutions like the ZAOSONiC and Diamond forceps, with an underlying aim of restoring patients’ lost functions.

The ZAOSONiC offers the advantage of delicately shaving bone without damaging surrounding tissue, ensuring minimal invasiveness in treatment procedures. The Diamond forceps perform grasping thin & slippery tissues firmly, facilitating precise manipulation during surgical interventions.



Our aim is to provide the highest quality, considering not only the welfare of patients and healthcare providers but also the broader landscape of social security and healthcare structures,” says company president Masaaki Hayashi. A portable device for Meniere's disease garnered recognition, a testament to its QOL dedication to patient-centric innovation.

Decisive efforts to increase its international presence, and navigating the challenges in adapting to different healthcare systems, the company is now targeting the likes of Australia, India, and Saudi Arabia for growth.



"We would like to change the world with our unique ENT device and expert staff," Mr. Hayashi concludes, envisioning a future that echoes Daiichi Medical's commitment to transforming lives.

  0 COMMENTS